All times are listed in CEST (Central European Summer Time)

Browsing Over 215 Sessions

Sort By
View
Channel 5

AstraZeneca - Re-evaluating the role of gBRCA in breast cancer

Date
Fri, 17.09.2021
Time
10:30 - 12:00
Chairs
  • Sibylle Loibl (Neu-Isenburg, Germany)
Channel 6

Novartis - Unmet needs in oncogene-driven NSCLC: how do we close the gap?

Date
Fri, 17.09.2021
Time
10:30 - 12:00
Chairs
  • Federico Cappuzzo (Ravenna, Italy)
Channel 3

MSD - Evolving Treatment Landscape in HNSCC 

Date
Fri, 17.09.2021
Time
18:45 - 20:15
Chairs
  • Jean-Pascal Machiels (Woluwe-Saint-Lambert, Belgium)
Channel 4

Medscape - A Stepwise  Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management 

Date
Fri, 17.09.2021
Time
18:45 - 20:15
Chairs
  • Joyce O'Shaughnessy (Dallas, United States of America)
Channel 5

Bayer - Taking action in nmCRPC: Cases in the clinic

Date
Fri, 17.09.2021
Time
18:45 - 20:15
Chairs
  • Bertrand Tombal (Brussels, Belgium)
  • Alicia K. Morgans (Boston, MA, United States of America)
Channel 6

Merck - Current and future treatments for head and neck cancer

Date
Fri, 17.09.2021
Time
18:45 - 20:15
Chairs
  • Kevin J. Harrington (London, United Kingdom)
Channel 3

Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Date
Sat, 18.09.2021
Time
08:45 - 09:45
Chairs
  • Nicolas Girard (Paris, France)
Channel 4

MSD - Transforming the Adjuvant Treatment Paradigm in Melanoma

Date
Sat, 18.09.2021
Time
08:45 - 10:15
Chairs
  • Alexander M. Eggermont (Utrecht, Netherlands)
Channel 5

Novartis - Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future

Date
Sat, 18.09.2021
Time
08:45 - 10:15
Chairs
  • Eric Van Cutsem (Leuven, Belgium)
Channel 6

MSD - Implementation of Immunotherapy in the First-Line Treatment of Esophageal, Gastroesophageal Junction and Gastric Cancers

Date
Sat, 18.09.2021
Time
08:45 - 10:15
Chairs
  • Sylvie Lorenzen (Munich, Germany)
Channel 3

Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world 

Date
Sat, 18.09.2021
Time
10:30 - 12:00
Chairs
  • Veronique C. Dieras (Rennes, CEDEX 5, France)
Channel 4

Amgen - Precision therapy in NSCLC: the dawn of KRAS G12C inhibition  

Date
Sat, 18.09.2021
Time
10:30 - 12:00
Chairs
  • Michael Thomas (Heidelberg, Germany)